I have tried to find comparable examples, but with little success. Best I could find was a company being taken over primarily for 1 drug that was seen as a possible block buster.
It was very late in the trial process, so it had been as about as de-risked as you could hope for [Refer RA's comments about waiting] and the price paid was 3 times the estimated revenue that would be generated. The IPO in 2009 was around $150 million US dollars, Not sure how much patent time was left.
So Monepantel as a drug could make the owner ??? Patents start to expire starting 2032 for Canine/Human cancer and 2040 for antiviral. So a reasonably long runway for a company to get their money back.
Remember RA has said he thinks 1 company will take all the licenses. Not sure if he was including the Doggies in that.
Does anyone have any evidence of similar situations ?
Pete
Ann: AGM Presentation, page-63
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |